1 domain / 2 areas / 1 specialization
Ark Invest
Data updated
ARK Invest, legally ARK Investment Management LLC, is an active investment manager founded by Cathie Wood in 2014. It is based in New York, United States, and focuses on disruptive innovation across public markets, with some private-market exposure through ARK Venture Fund.
ARK has published dedicated research on psychedelic therapeutics and the field’s clinical and commercial potential. Its public research and thematic investment approach make it a relevant institutional stakeholder for psychedelic drug development companies, especially those advancing novel therapies into clinical and public-market stages.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
ARK Invest is best known for thematic, research-driven investing in disruptive innovation, with portfolios that span public equities and, through ARK Venture Fund, private/public crossover exposure. In psychedelics, ARK’s relevance comes primarily from its public research coverage of psychedelic therapeutics and its willingness to allocate to frontier life-science themes that may progress from development-stage companies into broader public-market strategies.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 2014
- HQ
- New York, New York, United States
- Website
- Visit